Chemed Corporation (NYSE: CHE) reported Q4 EPS of $3.96, $0.13 worse than the analyst estimate of $4.09. Revenue for the quarter came in at $522 million versus the consensus estimate of $524.19 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.